Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment
7/7/2014 7:05:13 AM
Nairobi, Kenya: Malaria treatment has received a major boost after a stronger and more convenient drug for both children and adults was launched at the weekend.
The drug - Coartem 80/480 - which was launched by Novartis Pharmaceuticals Company at a Nairobi hotel, has been designed to reduce the number of tablets taken per dose.
Kenya is the third country in Africa to receive the drug that will cost Sh600 per dose.
Help employers find you! Check out all the jobs and post your resume.
comments powered by